Aquyre Biosciences, Inc. — Form D

Aquyre Biosciences, Inc. of WESTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-23. The offering totals $10.0M, of which $3.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Floyd Samuel Eberts, IIIDirectorWeston, MA
Aurelio James FernandezDirectorWeston, MA
Bertrand Samuel Le Conte Chrestien de PolyDirectorWeston, MA
Cosme James OrdonezDirectorWeston, MA
Ronald James SorensonDirectorWeston, MA
Claude Samuel BoccaraExecutive OfficerWeston, MA
Gregory Samuel BowlesExecutive OfficerWeston, MA
Floyd Samuel Eberts, IIIExecutive OfficerWeston, MA
Francois Samuel GrammontExecutive OfficerWeston, MA
Bertrand Samuel Le Conte Chrestien de PolyExecutive OfficerWeston, MA
Richard Samuel McCannExecutive OfficerWeston, MA
Thierry ThaureDirectorSan Jose, CA
Thierry ThaureExecutive OfficerSan Jose, CA
Aurelio FernandezDirectorAustin, TX
Bertrand Le Conte Chrestien de PolyDirectorBoston, MA
Bertrand Le Conte Chrestien de PolyExecutive OfficerBoston, MA
Aldo MaccariDirectorBoston, MA
Ari AzhirDirectorBoston, MA
Michael AlbinDirectorEXTON, PA

Other filings by this issuer (5)

FiledFormOfferingSold
2022-05-27D/A$5.5M$5.4M
2022-05-13D/A$5.0M$5.0M
2022-04-14D/A$5.0M$3.7M
2022-03-09D$2.0M$2.0M
2021-10-13D$38.0M$19.9M

More